
Dr Irina Buckle
85 posts

Dr Irina Buckle
@Irina_Buckle
Cinnamon loving citizen of the world; Immunologist working to find cure for T1D; wife, mummy of two beautiful people and one very fluffy Maltese puppy dog 🐶




#ASI2022MEL @mscienceaustnz #LaffertyDebate @K_RenfreeShort @CvandeSandt @_fernace @shalinhnaik @DrAshHaque @sumaira_hasnain @ASImmunology @stutangye

Type 1 #diabetes is mediated by CD8 T cell destruction of islet beta cells. Buckle et al @emmahwlab @TRI_info shares a promising study at #ASI2022MEL: delivery of a dominant CD8 epitope + an immunomodulator in liposomes can blunt the attack & delay diabetes in mice. @ASImmunology

Here is our talented team of bakers and walkers for #Type1Diabetes research!









Insightful presentations from Prof. Helen Thomas (centre), Head of Immun. & Diabetes Unit @SVIResearch & @dougaledwards, CEO @BrightArena at today’s @TRI_info's Research Translation Seminar. They discussed ‘Effica Biolabs: Accelerating the devt. of Type 1 #diabetes therapies’.




#Type1Diabetes is mediated by T cell destruction of islet β cells. In this month's Editor's Choice, Buckle et al @emmahwlab @TRI_info show delivery of a dominant CD8 epitope + an immunomodulator in liposomes can blunt the attack as a promising new therapy onlinelibrary.wiley.com/doi/epdf/10.11…

#Type1Diabetes is mediated by T cell destruction of islet β cells. Buckle et al @emmahwlab @TRI_info show delivery of a dominant CD8 epitope + an immunomodulator in liposomes can blunt the attack. A promising new therapy? @CEIjournal #100YearsofInsulin onlinelibrary.wiley.com/doi/10.1111/im…





